Vaccines Summit Boston 2024

#VSBOSTON24
June 18-20, 2024
Make sure you are at the forefront of the vaccine industry. No matter where your interest lies, we have content, networking, and potential partners for you.
About Vaccines Summit Boston

The Vaccines Summit Boston is an esteemed annual event dedicated to bringing together leading experts, researchers, policymakers, industry professionals, and stakeholders from around the world to discuss and collaborate on important aspects of vaccines and immunization. The upcoming Vaccines Summit Boston 2024 will mark its fourth edition and is anticipated to be an insightful and impactful gathering. VSBOSTON24 aims to provide a platform for sharing knowledge, research findings, and innovative approaches in the field of vaccines. It will serve as a forum for engaging in discussions, exploring emerging trends, and addressing critical challenges faced by the global healthcare community.

APPLY TO SPEAK

At A Glance
DATE:
June 18-20, 2024
LOCATION:
Hilton Boston/Woburn
2 Forbes Rd, Woburn, MA 01801
CONTACT:
Sachin Sravan
sachin@bsc.events
KEY OBJECTIVES
Knowledge Exchange
The summit will facilitate the exchange of scientific knowledge, best practices, and evidence-based strategies related to vaccines and immunization. Participants will have the opportunity to learn from experts in various disciplines and gain valuable insights into the latest advancements in vaccine research, development, and delivery.
Global Health Impact
The Vaccines Summit Boston 2024 will emphasize the global health impact of vaccines. Participants will explore the role of vaccines in preventing and controlling infectious diseases, reducing healthcare disparities, and achieving universal immunization coverage. Discussions will also address vaccine equity, access in low-resource settings, and the role of vaccination in pandemic preparedness.
Collaboration & Networking
Vaccines Summit Boston 2024 will foster collaboration and networking among professionals involved in vaccine research, manufacturing, regulation, distribution, and healthcare delivery. Participants will have ample opportunities to establish meaningful connections, form partnerships, and engage in interdisciplinary collaborations.
Emerging Trends and Innovations
The event will showcase cutting-edge research, technologies, and innovations in the field of vaccines. Attendees will gain insights into novel approaches, such as mRNA vaccines, vector-based vaccines, and personalized immunization strategies. Discussions will encompass advancements in vaccine manufacturing, storage, cold chain logistics, and delivery systems.
Policy and Advocacy
The summit will focus on policy discussions and advocacy efforts to promote the importance of vaccines and immunization at local, national, and global levels. Policymakers, public health officials, and stakeholders will explore strategies to address vaccine hesitancy, enhance vaccine accessibility, and strengthen immunization programs worldwide.

WHO SHOULD ATTEND?

C-Level Executives
Senior Scientists
Decision Makers
Presidents, VPs & SVPs
Drug developers
Academicians
Manufacturers
Researchers & Developers
Directors
Healthcare professionals
Product Developers
Regulatory Specialists
Principal Investigators
Consultants

SESSION TRACKS

Vaccine Immunology
Vaccine Development & Design
Vaccine Safety & Adverse Events
Vaccine Trials & Clinical Development
Vaccine Surveillance & Epidemiology
Vaccine Manufacturing & Quality Control
Vaccine Interactions & Combination Vaccines
Vaccine Resistance & Escape Mutants
Vaccine Pharmacovigilance & Post-Marketing Surveillance
Vaccines Formulation & Bioprocess
VSBOSTON24 Speakers
Victor Suarez
Founder and Principal Growth Partner, Blu Zone Bioscience & Supply Chain Solutions, Colonel, U.S. Army (Retired)
Daniel Salmon
Professor, Director of the Institute for Vaccine Safety, Johns Hopkins University
Margherita Coccia
Director, Adjuvant Science and Technology, GSK
Lloyd Jeffs
Senior Director of Biopharma Services, Cytiva
Ying Yu
Director of Business Development, Precision NanoSystems ULC. (part of Cytiva)
Arthur M Krieg
Adjunct Professor at UMass Chan Medical School RNA Therapeutics Institute
Rama Rao Amara
Professor, Emory Vaccine Center
Bijan Almassian
President & CEO, CaroGen Corporation
Dr. Adrian Hill
Director of the Jenner Institute, Lakshmi Mittal & Family Professor of Vaccinology, Professor Of Human Genetics, Oxford University, UK
Dr. Philip Dormitzer
Senior Vice President and Global Head of Vaccines Research and Development,GSK, USA
Kevin P Killeen
Chief Scientific Officer, Matrivax, USA
Dr. Jacob Glanville
Chief Executive Officer & President ,Centivax, USA
Patricia Mechael
Senior Associate, Department of International Health, Johns Hopkins Bloomberg School of Public Health, USA
Dr. Derek O'Hagan
Senior Advisor Vaccines R&D, GSK, USA
Dr. Denise L Faustman
Director of Immunobiology, Massachusetts General Hospital, USA
Dr. Alessandro Sette
Professor and Member, La Jolla Institute for Immunology, Division of Vaccine Discovery, University of California, USA
Dr. Christopher Locher
CEO & Co-Founder, Versatope Therapeutics, Inc., USA
Dr. Trina Racine
Director - Vaccine Development, Vaccine and Infectious Disease Organization (VIDO), Canada
Dr. Mark C Poznansky
Director – Vaccine and Immunotherapy Center (VIC), Massachusetts General Hospital, USA
Dr. John Fulkerson
Executive Director, Vaccines and Infectious Diseases, MESOSCALE, USA
Dr. Tzachi Pilpel
Professor and Head, Department of Molecular Genetics, Weizmann Institute of Science, Israel
Dr. Luigi Buonaguro
Director, Innovative Immunological Models Unit, National Cancer Institute "Pascale", Italy
Dr. Prakash Bhuyan
Chief Medical Officer, Aerium Therapeutics, USA
Dr. Njoh Andreas Ateke
Deputy Permanent Secretary, Expanded Program on Immunization, Cameroon
Dr. Tamir Tuller
Professor, Director of Laboratory of Computational Systems and Synthetic Biology, Tel Aviv University, Israel
Dr. Charles Jones
Senior Director, mRNA Commercial Strategy & Innovation, Pfizer, USA
Dr. Dan Barouch
Professor of Immunology, Harvard Medical School, USA
Juliana Melgaço
Research and development Analyst, FIOCRUZ, Brazil
Dr. Junhua Pan
Professor, Department of Biomedical Sciences, Hubei University of Technology, China
Sandeep Basnet
Director, Clinical Development, Moderna
Rebecca Loomis
Senior Project Leader - Viral Vaccines, GSK
VSBOSTON23 Advisory Board Members
Luis Ríos Nogales Garces
Executive Vice President & Chief Development Officer, ILiAD Biotecnologies, USA
William R. Jacobs Jr.
Leo & Julia Forchheimer Chair, Microbiology and Immunology, Albert Einstein College of Medicine, USA
Don J. Diamond
Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, USA

Mid Registration Closes on April 30, 2024

COMMERCIAL

$1750

$949

ACADEMIC

$1450

$699

STUDENT

$599

$350

Cancellation Policy
ALL CANCELLATIONS MUST BE SENT BY EMAIL AT sachin@bsc.events
Cancellations received up and including November 18, 2023: Full refund less a $150 towards the administrative fee.
Cancellations received between November 19 until March 21, 2024: 50% will be refunded.
Cancellations received After March 21, 2024: No refund will be made.
Group Registration
If you would like to register a team of 3 or more, please contact:sachin@bsc.events

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

* indicates required
Vaccine Summit Boston 2023 Sponsors

Gold Sponsor

Silver Sponsor

Bronze Sponsor

Sponsors & Partners
Vaccines Summit Boston 2024 provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Vaccines Summit Boston will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
For sponsorship and exhibition opportunities, please contact:

Sachin Sravan
Email: sachin@bsc.events
Phone: +91 9160 331 607
VSBOSTON23 Attendees
VENUE

Boston Marriott Newton Hotel

2345 Commonwealth Avenue, Newton, MA 02466

We have blocked limited rooms for our attendees at the hotel. You can confirm your accommodation booking at the discounted charges through the registration page.

For additional queries regarding accommodation, please contact: sachin@bsc.events